Anti-P110 Autoantibodies Identify a Subtype of “Seronegative” Myasthenia Gravis With Prominent Oculobulbar Involvement

Laboratory Investigation - United Kingdom
doi 10.1097/01.lab.0000028144.48023.9b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oculobulbar Myasthenia Gravis in an Octogenarian

Journal of Medical Cases
2013English

Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

JAMA Neurology
Neurology
2016English

Clinical and Immunological Associations in Myasthenia Gravis. 1: Autoantibodies.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1980English

Peripheral Plasmablasts in Anti-MuSK Myasthenia Gravis

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2017English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Myasthenia Gravis

JAMA - Journal of the American Medical Association
Medicine
2005English

Complete Remission Induced by Rituximab in Refractory, Seronegative, Muscle-Specific, Kinase-Positive Myasthenia Gravis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy